XML 30 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value
12 Months Ended
Jun. 30, 2018
Compensation Related Costs [Abstract]  
Deferred Compensation
4.    Fair Value

The available-for-sale marketable securities are primarily comprised of investments with a fixed income and equity investments and consist of the following, measured at fair value on a recurring basis:
 
 
 
Fair Value Measurements as of June 30, 2018 Using Inputs Considered as
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
Mutual funds
$
544

 
199

 
345

 
$

   Total marketable securities
$
544

 
199

 
345

 
$

 
 
 
Fair Value Measurements as of June 30, 2017 Using Inputs Considered as
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
Mutual funds
$
704

 
281

 
423

 
$

   Total marketable securities
$
704

 
281

 
423

 
$



During the years ended June 30, 2018 and 2017, there were no purchases of available-for-sale securities and $194 and $40, respectively, of available-for-sale securities that were sold. There were no other-than-temporary impairments during the years ended June 30, 2018 and 2017. During the years ended June 30, 2018 and 2017, there was a realized gain of $34 and $6 that was recorded within interest income and other, net on the consolidated statement of operations.

There were no transfers of assets between Level 1 and Level 2 of the fair value measurement hierarchy during the year ended June 30, 2018. Any transfers between levels are recognized on the date of the event or when a change in circumstances causes a transfer.

Cost Method Investment

The Company holds a cost method investment measured at fair value on a nonrecurring basis and is classified as a Level 3 investment. As of June 30, 2018, the cost of the investment was $2,538. There were no identified events or changes that had a significant adverse effect on the fair value of the investment. The investment is recorded within other long term assets on the consolidated balance sheet.